Article

A New Era of Disease‐Modifying Pharmacotherapy in Cardiovascular Medicine

2025-12-10

Abstract excerpt

<h4>Background: </h4> /Objectives: Cardiovascular disease (CVD) remains the leading cause of global morbidity and mortality. Although substantial therapeutic advances have been made over the past decades, the years 2024–2025 mark a turning point characterized by the emergence of mechanistically innovative, disease-modifying therapies that go beyond conventional risk-factor control. This narrative review aims to sy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f7fd4183-5ef7-53a0-ab6c-82e62b3dbd58
DOI: 10.20944/preprints202512.0979.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A New Era of Disease‐Modifying Pharmacotherapy in Cardiovascular MedicineDOI 10.20944/preprints202512.0979.v1Read

Pharmacogenomics in cardiac therapy: Personalizing treatment for heart healthSemantic proximity Read

Emerging Pharmacological Strategies for Cardiac Amyloidosis: A Qualitative Analysis of Interventional Clinical Trials Registered on ClinicalTrials.govSemantic proximity Read

Cardiovascular Pathologies: A Comprehensive Review of Mechanisms, Risk Factors, and Advanced Therapeutic ModalitiesSemantic proximity Read

Precision Medicine and Personalized Medicine in Cardiovascular Disease.Semantic proximity Read

Personalized Management of Cardiovascular Disorders.Semantic proximity Read

Beyond the 2025 guidelines: tailoring hypertension management to the underlying pathogenic pathway in the age of precision medicine.Semantic proximity Read

A systems‑level scoping review of multi‑omic markers in obesity‑ and type 2 diabetes‑associated diastolic dysfunction: An integrated three‑module frameworkSemantic proximity Read

Hypertrophic cardiomyopathy: a practical approach to guideline directed management.Semantic proximity Read

Hypertrophic Cardiomyopathy and Phenocopies: New Therapies for Old Diseases—Current Evidence and Future PerspectivesSemantic proximity Read

Unraveling the Complexity: From Molecular Subtypes to Therapeutic Strategies in Heart Failure with Preserved Ejection Fraction and Atrial FibrillationSemantic proximity Read

Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.Semantic proximity Read

[Hypertrophic cardiomyopathies and ATTR amyloidosis - a current review for clinical practice].Semantic proximity Read